The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Khamaganova I.V.

Russian State Medical University, Moscow

Novozhilova O.L.

Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia Moskvy, 119071, Moskva, Rossiĭskaia Federatsiia

Lebedeva G.A.

Otdelenie meditsinskikh osmotrov po dermatovenerologii Departamenta zdravookhraneniia, Moskva

Epidemiology of rosacea

Authors:

Potekaev N.N., Khamaganova I.V., Novozhilova O.L., Lebedeva G.A.

More about the authors

Read: 3506 times


To cite this article:

Potekaev NN, Khamaganova IV, Novozhilova OL, Lebedeva GA. Epidemiology of rosacea. Russian Journal of Clinical Dermatology and Venereology. 2016;15(1):4‑7. (In Russ.)
https://doi.org/10.17116/klinderma20161514-7

Recommended articles:
Risk factors of inte­rnal caro­tid artery tortuosity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):150-155
Retrospective analysis of sexually transmitted infe­ctions inci­dence in countries of the world. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):132-142
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Damage of human skin barrier components in expo­sure of Demo­dex specimens. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):219-226
Expe­rience of comprehensive treatment of erythematotelangiectatic rosa­cea. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):236-239
Premature birth and obesity: epidemiology, pathogenesis and obstetric tactics. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):29-34
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124

References:

  1. Potekaev N.N. Rozatsea. M. SPb. 2000.
  2. Potekaev N.N., Demidova L.M., Shuginina E.A. Mikrotokovaya terapiya: perspektivy primeneniya v kosmetologii; rol' mikrotokov v lechenii rozatsea. Vestnik esteticheskoi meditsiny. 2010;9:3:6-12.
  3. Samodelkina K.A., Korotkii N.G., Mayatskaya T.V. Sovremennye kontseptsii etiologii i patogeneza rozatsea. Klinicheskaya dermatologiya i  venerologiya. 2012;3:4-8.
  4. Chosidow O, Cribier B. Epidemiology of rosacea: updated data. Ann Dermatol Venereol. 2011;138 Suppl 3:179-183. 
  5. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6 Suppl 1):15-26. 
  6. Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci. 2009;55(2):77-81. 
  7. Gerber PA, Buhren BA, Steinhoff M, Homey B. Rosacea: The cytokine and chemokine network. J Investig Dermatol Symp Proc. 2011;15(1):40-47. 
  8. Mc Aleer MA, Lacey N, Powell FC. The pathophysiology of rosacea. G Ital Dermatol Venereol. 2009;144(6):663-671.
  9. Czepita D, Kuźna-Grygiel W, Czepita M, Grobelny A. Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis. Ann Acad Med Stetin. 2007;53(1):63-67.
  10. Chen W, Plewig G. Human demodicosis: revisit and a proposed classification. Br J Dermatol. 2014;170(6):1219-1225.
  11. Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013;69(6 Suppl 1):27-35. 
  12. Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol. 2012;167(3):598-605. 
  13. Lazaridou E, Apalla Z, Sotiraki S, Ziakas NG, Fotiadou C, Ioannides D. Clinical and laboratory study of rosacea in northern Greece. J Eur Acad Dermatol Venereol. 2010;24(4):410-414.
  14. Schaefer I, Rustenbach SJ, Zimmer L, Augustin M. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology. 2008;217(2):169-172. 
  15. Abram K, Silm H, Oona M. Prevalence of rosacea in an Estonian working population using a standard classification. Acta Derm Venereol. 2010 May;90(3):269-273. 
  16. Spoendlin J, Voegel JJ, Jick SS, Meier CR. Spironolactone may reduce the risk of incident rosacea. J Invest Dermatol. 2013 Oct;133(10):2480-2483.
  17. Spoendlin J, Voegel JJ, Jick SS, Meier CR. Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom. J Am Acad Dermatol. 2013;69(3):399-406. 
  18. Mebazaa A, Aounallah A, Naija N, Cheikh Rouhou R, Kallel L, El Euch D, Boubaker J, Mokni M, Filali A, Ben Osman A. Dermatologic manifestations in inflammatory bowel disease in Tunisia. Tunis Med. 2012;90(3):252-257.
  19. Spoendlin J, Voegel JJ, Jick SS, Meier CR. Antihypertensive drugs and the risk of incident rosacea. Br J Dermatol. 2014 [Epub ahead of print].
  20. Spoendlin J, Bichsel F, Voegel JJ, Jick SS, Meier CR. The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea. Br J Dermatol. 2014 Apr;170(4):878-883.
  21. Spoendlin J, Voegel JJ, Jick SS, Meier CR. Risk of rosacea in patients with diabetes using insulin or oral antidiabetic drugs. J Invest Dermatol 2013;133(12):2790-2793.
  22. Chamaillard M, Mortemousque B, Boralevi F, Marques da Costa C, Aitali F, Taïeb A, Léauté-Labrèze C. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol. 2008;144(2):167-171. 
  23. Webster G, Schaller M. Ocular rosacea: a dermatologic perspective. J Am Acad Dermatol. 2013;69(6 Suppl 1):42-43. 
  24. Oltz M, Check J. Rosacea and its ocular manifestations. Optometry. 2011;82(2):92-103. 
  25. Khamaganova I.V., Ikonnikova N.A., Galkina O.A. Trikhopol v kompleksnoi terapii rozatsea. Con med. Prilozhenie «Dermatologiya» 2005;22-25.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.